Breast cancer is one of the most common malignancies. It is necessary to identify new markers for predicting tumor progression and therapeutic molecular targets. It has been reported that CD147 is one of the most commonly expressed proteins in primary tumors and in metastatic cells. In this study, we investigated the role of CD147 in human breast cancer metastasis and invasion, and examined its underlying molecular mechanisms. Immunohistochemistry results revealed high expression of CD147 in human breast tumor tissues, which was positively correlated with the malignancy of breast cancer. MCF-7 cells were transfected with CD147 siRNA eukaryotic expression vector, which resulted in significant knockdown of CD147. We found that CD147 siRNA dramatically inhibited cell proliferation, metastasis, and invasion. Furthermore, our results demonstrated that CD147 siRNA inhibited the synthesis of matrix metalloproteinase 9 (MMP-9) but had no significant effect on matrix metalloproteinase 2 (MMP-2). In addition, CD147 siRNA significantly inhibited the production of vascular endothelial growth factor (VEGF). Taken together, these data indicate that CD147 promotes breast cancer cell proliferation, metastasis, and invasion by modulating MMP-9 and VEGF expression. Thus, CD147 may be used as an important indicator for the judgment of malignant behavior of breast cancer, and may be a potential novel target for breast cancer therapy.
Introduction
Breast cancer has become the most common malignancy in women worldwide, and it is the major cause of cancer-related deaths in women [1] . In recent years, the integrated application of early diagnosis, postoperative radiotherapy, chemotherapy, hormone therapy, and molecularly targeted therapy has resulted in a decline in the breast cancer death rate [2] [3] [4] [5] [6] . However, breast cancer recurrence and metastasis, especially in the distant metastases, remain the biggest challenge for clinicians [1, [7] [8] [9] .
The role of CD147 in the tumor metastatic infiltration process and its tumor therapeutic value are currently a focus of attention [10] [11] [12] . CD147, also known as extracellular matrix metalloproteinase inducer (EMMPRIN), is a transmembrane protein that belongs to the immunoglobulin superfamily. In normal tissue, CD147 expression is low, but its expression is increased in multiple solid tumors. It is also associated with malignancy and invasion status of tumors [10, 13, 14] . CD147 is chiefly involved in cell-cell or cellmatrix interactions. These include: (i) stimulating tumor cells and their associated stromal fibroblasts to produce matrix metalloproteinases (MMPs); (ii) degrading the extracellular matrix (ECM) and basement membrane; (iii) destructing natural barriers; and (iv) promoting the progression of malignant tumors [15] [16] [17] [18] . MMPs represent a highly regulated family of structurally related enzymes capable of degrading most of the components of ECM [16] . Several MMPs are thought to be important in the process of angiogenesis, especially MMP-9 and MMP-2. These two MMPs preferentially degrade basement membrane components such as type-IV collagen, unmask cryptic biologically relevant sites in ECM components, modulate angiogenic factors, and are involved in the production of endogenous angiogenic inhibitors [17] .
Tumor growth and metastasis require angiogenesis once the tumor reaches a diameter of 1-2 mm [19] . Angiogenesis is the physiological process through which new blood vessels form from pre-existing vessels. It occurs as a result of a series of events, which begin with the disruption of the endothelial cell basement membrane and ECM by proteolytic enzymes [20] . Degradation of the ECM releases basement membrane-sequestered angiogenic factors, such as vascular endothelial growth factor (VEGF). VEGF is a key modulator of angiogenesis and may play an important role in the survival, proliferation, and metastasis of tumor cells [21] .
The metastasis and invasion of breast cancer is a complex process that includes tumor cell proliferation, extracellular matrix and basement membrane degradation, tumor cell migration and microvascular formation [22, 23] . Metastatic breast cancer is the primary cause of cancer mortality in women [24] . The correlation between CD147 expression and breast cancer metastasis has not been reported.
The purpose of this study was to explore the role of CD147 in breast cancer cell metastasis and invasion and its related molecular mechanisms, providing a theoretical and experimental basis for CD147 used as a potential new target for the clinical treatment of breast cancer.
Materials and Methods

Patient samples and immunohistochemistry
A total of 56 tissue specimens (subject age: 26-75 years; median subject age: 56 years) and 20 normal adjacent tissues were collected from breast cancer patients, which were obtained from Shanxi Provincial Cancer Hospital (Taiyuan, China). Informed consent was obtained from all patients. Immunohistochemical staining was performed on formalin-fixed, paraffin-embedded tissue sections, which had been obtained from routine diagnostic techniques. The slides were dewaxed with xylene and rehydrated through graded alcohols. Following immersion in citrate buffer for antigen retrieval under pressure, the slides were placed in 3% H 2 O 2 for 15 min. The slides were incubated with a primary anti-CD147 antibody (Abcam, Cambridge, UK) overnight at 4°C. After being washed with PBS, they were incubated with the secondary antibody for 30 min. The slides were then incubated with DAB for 5 min and counterstained with 20% hematoxylin, dehydrated, cleared, and mounted [25] .
Immunohistochemical staining of cells was assessed according to stain intensity and extent (proportion of stained cells). The intensity of the immunostaining was graded using a 4-point scale: 0, no staining; 1, weak staining; 2, moderate staining; and 3, strong staining. The percentage of stained cells was assessed using a semiquantitative 4-point scale: 1, <25% positive tumor cells; 2, 25%-50% positive tumor cells; 3, 51%-75% positive tumor cells; and 4, >75% positive tumor cells. The results of staining intensity and extent were graded as follows: 0, negative (−); 1-4, weak positive (±); 5-8, moderate positive (+); and 9-12, strong positive (++). The scores of <5 were considered negative and the scores of ≥5 were considered positive for CD147 expression [26] .
Cell line and reagents
The human breast cancer cell line MCF-7 was preserved in our laboratory [27, 28] 
RNA extraction, reverse transcription-PCR and quantitative real time-PCR
Total RNA was extracted from cells using Trizol (Invitrogen). Firststrand cDNA was synthesized and then the newly synthesized cDNA was amplified by PCR. Primers are shown in Table 1 . For reverse transcription-PCR of CD147, the conditions for the amplification cycle were as follows: 95°C for 2 min, 95°C for 15 s, 56°C for 30 s, 72°C for 30 s, for 40 cycles, followed by 72°C for 5 min. Aliquots of the PCR product were separated by agarose gel electrophoresis using 1.5% agarose sugar. PCR fragments were visualized with ethidium bromide staining under ultraviolet light. Quantitative real-time PCR (qRT-PCR) of MMP-9, MMP-2 and VEGF was performed on cDNA using SYBR green PCR Master Mix (Promega, Madison, USA). PCR was performed on the Real Time PCR Machine 7500 (Applied Biosystems, Foster City, USA) using the following conditions: 95°C for 2 min, 95°C for 15 s, and 60°C for 60 s for 40 cycles; followed by 72°C for 7 min. β-actin was used as an internal control and the comparative ΔΔCt method was employed to determine the relative expression levels. The PCR reaction had a total volume of 25 μl that contained 0.5 μl of cDNA template. The experiment was repeated in triplicate.
Western blot analysis
For western blot analysis, 1 × 10 6 cells were collected and lysed with ice-cold RIPA buffer (Beyotime) for 30 min. The protein concentration was determined using the BCA method. The protein was separated by 15% SDS-PAGE and transferred onto PVDF membranes (Beyotime). The membranes were blocked with 5% bovine serum albumin in Tris-buffer saline (TBST) at 37°C for 1 h. They were then incubated with primary antibodies overnight, and followed by incubation with an HRP-conjugated secondary antibody (Beyotime) for 1 h at room temperature. The protein bands were visualized using the enhanced chemiluminescence (ECL) detection kit (Beyotime). The density of each band was normalized to β-actin. Fluorescence intensity was quantified via Image J software.
Cell proliferation assay
The cell proliferation was determined by Cell Counting Kit-8 staining according to the manufacturer's instructions. Cells were seeded in 96-well plates at initial density of 6 × 10 3 cells/well. At 24, 48, and 72 h, the cells were respectively stained with 10 μl CCK8 dye in 90 μl culture medium for 1 h at 37°C. The absorbance was measured at 450 nm using a microplate reader (BioTek, Synergy Mx, USA). All experiments were performed in triplicates.
Wound healing assay
Cell migration activity was measured by wound healing assay. Briefly, cells were grown in complete culture medium to monolayer confluence in 24-well tissue culture plates. After scratching with a pipette tip, the cells were cultured in serum-free culture medium for 24 h. Then, cells were washed three times with PBS solution and photographed. The width of the scratches was measured at 0 and 24 h. Percent of closure = (1 − width of scratches/initial width of scratches) × 100%. The experiment was repeated three times [30] .
Transwell assay
Cell invasion activity was measured by transwell assay. Matrigel was coated onto each well of a 24-Transwell invasion plate and incubated for 2 h. In serum-free media, 50,000 cells were seeded in the top chamber; the bottom chamber contained 10% FBS in DMEM medium. After 48 h, the cells from the upper chamber were removed using a cotton swab, and the cells that invaded the Matrigel were fixed with 3.7% formaldehyde for 10 min. They were then stained with 0.2% crystal violet for 20 min. Images of the invading cells were photographed using an inverted microscope (Olympus, Tokyo, Japan) (×20), and the number of cells was counted and quantified by Image J software [30] .
Statistical analysis
Biostatistical analyses were conducted using the SPSS 13.0 software packages. One-way ANOVA and multiple comparisons were used to analyze the statistical significance between multiple groups. All experiments were done in triplicate and the results were from three independent studies. Results are expressed as the mean ± standard deviation (SD). P < 0.05 was considered to be statistically significant.
Results
Expression of CD147 protein in breast cancer tissue
The expression of CD147 protein was detected by immunohistochemical staining in 56 breast cancer samples and 20 normal adjacent tissues. As shown in Fig. 1 , the staining of CD147 was negative in adjacent normal tissues (Fig. 1A) , while breast cancer tissues showed elevated expression of CD147 in cell membrane of the breast cancer cells (Fig. 1B-D) . The immunohistochemical staining results were summarized in Table 2 . In breast cancer samples, 51.8% cases exhibited positive CD147 expression. In adjacent normal tissues, the only 5% sample displayed CD147 positive expression. There was a statistically significant difference between breast cancer samples and normal adjacent tissues (P < 0.001). These data indicated that CD147 was significantly upregulated in breast cancer and may be related to breast cancer tumorigenesis.
Overexpression of CD147 correlates with malignancy of breast cancer
Furthermore, the correlation between immunohistochemical staining of CD147 expression and the clinical pathological features of breast cancer was examined ( Table 3) . Our results showed that CD147 protein was more frequently expressed in tumors with histologic grade II and III (58.5%) than in those with histologic grade I (33.3%; P < 0.01). Meanwhile, CD147 protein was more frequently expressed with tumor size ≥ 3 cm (54.8%) than with tumor size < 3 cm (48.0%; P < 0.05). CD147 protein was more frequently expressed in tumors with lymph node metastasis (61.5%) than in those without metastasis (29.4%; P < 0.01). These results suggested that CD147 might play an important role in breast cancer tumorigenesis and progression, and might be an important biomarker in the judgment of malignancy of breast cancer. To confirm target gene knockdown, we used reverse transcription-PCR and western blot analysis to measure the expression of CD147 mRNA and protein, respectively. When comparing the MCF-7, the MCF-7-liposome, the MCF-7-liposome-Control siRNA and the MCF-7-liposome-CD147 siRNA groups, the mRNA level of CD147 in the MCF-7-liposome-CD147 siRNA group was significantly reduced (P < 0.01). CD147 protein expression was decreased in a similar manner to the mRNA results. There were no statistically significant differences observed between the MCF-7, MCF-7-liposome and the MCF-7-liposome-Control siRNA groups ( Fig. 2A,B , P > 0.05).
CD147 siRNA suppresses MCF-7 cell proliferation
Proliferation is a process that increases the number of cells through growth and division, and is increased in tumor cells. Thus, inhibiting cell proliferation is important to the treatment of tumors. To determine the effect of CD147 siRNA on the proliferation of MCF-7 cells, we used the CCK8 method. When compared to the MCF-7 group, the proliferation ability of the MCF-7-liposome-CD147 siRNA group was decreased by 77.4% (P < 0.01), 49.1% (P < 0.05), and 77.4% (P < 0.05) at 24, 48, and 72 h, respectively (Fig. 3) . When compared to the MCF-7-liposome group, it was decreased by 78.9% (P < 0.01), 50.1% (P < 0.05), and 78.9% (P < 0.05) at 24, 48, and 72 h, respectively (Fig. 3) . However, there was no statistically significant difference between the MCF-7 and MCF-7-liposome groups ( Fig. 3 , P > 0.05). These results demonstrated that CD147 can significantly promote the proliferation of MCF-7 cells.
CD147 siRNA inhibits MCF-7 cell migration and invasion
Metastasis and invasion are the most important biological characteristics of tumor cells. Thus, inhibiting metastasis and invasion is the most direct and effective method of tumor treatment. Therefore, we investigated the effects of CD147 siRNA on migration and invasion by a wound healing assay and a transwell chamber assay, respectively. The wound healing assay results revealed that the percent of closure at 24 h after scratching was: 83% in the MCF-7 group, 81% in the MCF-7-liposome group, and 25% in the MCF-7-liposome-CD147 siRNA group. Compared with both the MCF-7 liposome and MCF-7 groups, the percent of closure of MCF-7-liposome-CD147 siRNA group was significantly reduced (Fig. 4A , P < 0.05).
There was no significant difference between the MCF-7 and MCF-7-liposome groups ( Fig. 4A , P > 0.05). The transwell chamber assay results showed that the percent of invaded cells of the MCF-7-liposome-CD147 siRNA group was decreased by 88% (P < 0.01) and 87% (P < 0.01) compared to the MCF-7 group and the MCF-7-liposome group, respectively (Fig. 4B) . There was no significant difference between the MCF-7 and MCF-7-liposome groups ( Fig. 4B, P > 0.05) . These results suggested that CD147 has a positive regulatory effect on the migration and invasion of MCF-7 cells.
CD147 siRNA regulates metastasis and invasion by modulating MMP-9/VEGF expression
Experimental and clinical studies have shown a correlation between increased MMPs and tumor progression and metastasis [31] . Among various MMP types, MMP-2 and MMP-9 play crucial roles in tumor invasion and metastasis by degradation of ECM, leading to cancer cell spread to distal organs [32] . To explore whether CD147 promotes tumor progression by modulating MMP expression, we measured the mRNA level and protein expression of MMP-9 and MMP-2 by qRT-PCR and western blot analysis, respectively. Compared to both the MCF-7 and MCF-7-liposome groups, there was a significant decrease in MMP-9 mRNA level (75% and 71.4%, respectively; P < 0.05) in the MCF-7-liposome-CD147 siRNA group (Fig. 5A) . Additionally, protein expression of MMP-9 was significantly decreased by 71.4% and 63.6% (P < 0.05) in the MCF-7-liposome-CD147 siRNA group, as compared to the MCF-7 and MCF-7-liposome groups, respectively (Fig. 5B) . However, no significant difference was observed in MMP-2 mRNA level and protein expression of three different groups (P > 0.05). These results suggested that CD147 promotes tumor invasion and metastasis by upregulating MMP-9 expression but not MMP-2 expression. Moreover, MMPs comprise a family of zinc-dependent endopeptidases involved in the matrix degradation and tissue and vascular remodeling. MMPs are also involved in the activation and processing of factors related to angiogenesis and vascular stability [33] . VEGF, a potent angiogenic cytokine, is one of them. VEGF expression strongly correlates with that of MMPs [34] . Studies have also shown that VEGF and MMP regulate each other during tumor progression [35, 36] . Therefore, we investigated if RNA interference of CD147 regulates MMP-9-mediated VEGF expression in breast tumor angiogenesis. It was found that the mRNA level of VEGF in the MCF-7-liposome-CD147 siRNA group was significantly decreased by 61.5% and 59.5% (P < 0.01) when compared to the MCF-7 and MCF-7-liposome groups, respectively (Fig. 5A) . Additionally, the protein expression of VEGF in the MCF-7-liposome-CD147 siRNA group was significantly decreased by 86.7% and 84.6% (P < 0.01) when compared to the MCF-7 and MCF-7-liposome groups, respectively (Fig. 5B) . These findings Figure 2 . The efficiency of siRNA-mediated knockdown of CD147 in MCF-7 cells Cells were transfected with blank liposome, liposome-CD147 siControl or liposome-CD147 siRNA. 1: MCF-7 cells only group; 2: MCF-7-liposome group; 3: MCF-7-liposome-siControl group; 4: MCF-7-liposome-CD147 siRNA group. Total RNA and cell lysates were extracted from each group 48 h after transfection and used to detect the expression of CD147 at both the mRNA (A) and protein level (B) by RT-PCR and western blotting, respectively. Data were represented as the mean ± SD. **P < 0.01 compared with control group.
provided a mechanistic insight into MMP-9-regulated VEGF gene expression followed by invasion and migration in a breast cancer cell line.
Discussion
Numerous deaths resulting from breast cancer are caused by cancer cell invasion to the surrounding tissue and metastasis to distal tissues. Breast cancer metastasis is a complex process, which involves many genes that interact with and affect each other. Zhu et al. [23] reported that the Galectin-1 gene regulated several levels of MDA-MB-231 breast cancer cell metastasis, including migration, invasion, and proliferation. McFarlane et al. [37] demonstrated that CD44 promoted the invasive growth of breast cancer cells and played an important role in the distant metastasis of breast cancer. Miglietta et al. [38] suggested that increased expression of COX-2 promoted the excessive proliferation and transformation of precancerous cells and inhibited apoptosis. Datar et al. [39] demonstrated that RKIP suppressed tumor invasion and metastasis by mediating macrophage infiltration. Thus, there are many genes that affect the metastasis of breast cancer. Figure 3 . Effects of CD147 siRNA on the proliferation of MCF-7 cells After transfection, cells were cultured in RPMI 1640 medium containing 10% FBS for 24, 48 , or 72 h. Proliferation was measured using a CCK8 kit, and the color intensity was measured using a microplate reader at 450 nm. Data were represented as the mean ± SD of three replicates from separate experiments. *P < 0.05 and **P < 0.01 compared with control group. As a current hot spot in cancer research, CD147 is the most commonly expressed protein in both primary and micrometastatic cells [10] , suggesting that it plays a key role in tumor progression and early metastasis. Wu et al. [40] supported the use of soluble CD147 as a diagnostic marker in hepatocellular carcinoma (HCC) detection, especially for HCC with negative AFP and at the early stage of HCC. Piao et al. [41] reported that high CD147 expression was closely associated to the poor prognosis of salivary adenocarcinoma. Schneiderhan et al. [42] reported that CD147 promoted the malignant potential of pancreatic cancer cells by studying the effects of CD147 gene silencing. Similar to the above research reports, we found that CD147 protein was overexpressed in tumor cells membrane of the breast tumor tissues, and overexpression of CD147 was positively related to histological grade, tumor size, and lymph node metastasis of breast cancer. These data indicate that CD147 may be an attractive marker for malignant diagnosis of breast cancer. Additionally, after knocking down CD147 expression in MCF-7 breast cancer cells using siRNA approach, there was a significant reduction in CD147 mRNA level. Furthermore, CD147 protein expression results were consistent with the mRNA level. These results demonstrated that RNA interference of the mRNA structure hindered the translation process and prevented the expression of CD147 molecules.
Kendrick et al. [11] reported that CD147 genetic ablation prevented pancreatic cancer cell proliferation and tumor growth in vitro and in vivo in conjunction with metabolic rewiring towards amino acid anabolism, thus paving a way for future combined pharmacological treatments. Li et al. [43] suggested that CD147 was overexpressed in pancreatic cancer cell lines and tissues and served as the major player in CypA-CD147 interaction to promote cell proliferation in pancreatic cancer cells. Because CypA is a multifunctional protein that is involved in many basic cell functions such as protein folding and mitochondrial functions, an siRNA knockeddown CypA approach may affect cell survival. An siRNA approach may not be applicable to the exogenous CypA, which may play a role similar to a cytokine or growth factor. Alternatively, using CD147 blocking antibody could specifically block the effect of exogenous CypA on pancreatic cancer cell proliferation in Panc-1 cells. In our study, as expected, CD147 siRNA significantly suppressed MCF-7 cell proliferation, suggesting that CD147 plays an important and specific role in breast cancer cell proliferation, and might serve as a key signal transducer in breast cancer pathogenesis. To further verify the effects of CD147 siRNA on MCF-7 cell physiology behaviors, we examined the migration and invasion of MCF-7 cells in different groups and found that CD147 siRNA inhibited breast cancer cell migration and invasion. At the cellular level, we once again demonstrated the relevance of CD147 to breast cancer cells metastasis and invasion. For the identification of new diagnostic markers and therapeutic targets, it is important to elucidate the molecular mechanism by which CD147 promotes cancer cell proliferation, invasion, and metastasis.
CD147 is known as EMMPRIN because it has been shown to stimulate fibroblasts to secrete MMPs [17] . CD147 can bind to MMP to enrich MMP on the tumor cell surface, which enhances degradation of the surrounding tumor cell matrix and promotes the infiltration and dissemination of the tumor [44, 45] . In this study, we analyzed the changes of MMP-9 and MMP-2, two most classic MMPs, in different groups and found that the effects of CD147 on breast cancer cells were mediated by stimulating the synthesis of MMP-9. In addition, CD147 stimulates MMP to produce VEGF, which stimulates tumor vascular endothelial cells, promotes the reconstruction of tumor blood vessels, and enhances tumor cell proliferation and invasiveness [46, 47] . VEGF production in tumor cells is essential for tumor growth. Yang et al. [48] reported that CD147 was associated with the physiology of malignant ovarian cancer, including tumor invasion, metastasis, angiogenesis, and drug resistance. Breast lesions are vascular dependent, and multiple factors participate in its invasion and metastasis. Therefore, we further Figure 5 . Effects of CD147 siRNA on the expression of MMP-9, MMP-2 and VEGF MCF-7 cells were transiently transfected with blank liposome or liposome-CD147 siRNA. 1: MCF-7 cells only group; 2: MCF-7-liposome group; 3: MCF-7-liposome-CD147 siRNA group. Total RNA and cell lysates were extracted 48 h after transfection. Real time-PCR (A) and western blot analysis (B) of MMP-9, MMP-2 and VEGF expression. Data were represented as the mean ± SD. *P < 0.05 and **P < 0.01 compared with control group. studied the effects of CD147 siRNA on VEGF expression and the results revealed that CD147 is positively correlated with VEGF mRNA level and protein expression. These results suggest that CD147 may accelerate angiogenesis and tumor growth by inducing MMP-9 synthesis and VEGF production, promoting tumor invasion and metastasis.
In conclusion, our study indicates that CD147 is overexpressed in breast tumors and knockdown of CD147 suppresses the proliferation, migration and invasion of MCF-7 cells by downregulating MMP-9/VEGF expression. These results may significantly contribute to a better understanding the importance of CD147 for breast cancer. In the next step, we will further investigate the specific signal pathway of CD147 affecting breast cancer proliferation, metastasis, and invasion, and further verify the relationship between CD147 and breast cancer through animal models in vivo, which will provide a theoretical basis for the potential of CD147 as an attractive target in the development of new therapies against breast cancer.
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